ES2155752B1 - FORMULATIONS OF MONOMERIC INSULIN ANALOGS. - Google Patents

FORMULATIONS OF MONOMERIC INSULIN ANALOGS.

Info

Publication number
ES2155752B1
ES2155752B1 ES9802174A ES9802174A ES2155752B1 ES 2155752 B1 ES2155752 B1 ES 2155752B1 ES 9802174 A ES9802174 A ES 9802174A ES 9802174 A ES9802174 A ES 9802174A ES 2155752 B1 ES2155752 B1 ES 2155752B1
Authority
ES
Spain
Prior art keywords
formulations
monomeric insulin
insulin analogs
analog
protamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9802174A
Other languages
Spanish (es)
Other versions
ES2155752A1 (en
Inventor
Felippis Michael R De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/260,633 external-priority patent/US5461031A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES2155752A1 publication Critical patent/ES2155752A1/en
Application granted granted Critical
Publication of ES2155752B1 publication Critical patent/ES2155752B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Formulaciones de análogos de insulina monoméricos. La presente invención describe diversas formulaciones farmacéuticas parenterales, que comprenden: un análogo de insulina monomérico, cinc, protamina y un derivado fenólico. Las formulaciones de análogos proporcionan una duración prolongada de la actuación. También se describe un procedimiento para la preparación de formulaciones de análogo de insulina-protamina.Monomeric insulin analog formulations. The present invention describes various parenteral pharmaceutical formulations, comprising: a monomeric insulin analog, zinc, protamine and a phenolic derivative. Analog formulations provide a long duration of performance. A procedure for the preparation of insulin-protamine analog formulations is also described.

ES9802174A 1994-06-16 1995-06-14 FORMULATIONS OF MONOMERIC INSULIN ANALOGS. Expired - Fee Related ES2155752B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/260,633 US5461031A (en) 1994-06-16 1994-06-16 Monomeric insulin analog formulations
ES09501196A ES2091728B1 (en) 1994-06-16 1995-06-14 MONOMERIC INSULIN ANALOG FORMULATIONS.

Publications (2)

Publication Number Publication Date
ES2155752A1 ES2155752A1 (en) 2001-05-16
ES2155752B1 true ES2155752B1 (en) 2002-02-01

Family

ID=26154895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9802174A Expired - Fee Related ES2155752B1 (en) 1994-06-16 1995-06-14 FORMULATIONS OF MONOMERIC INSULIN ANALOGS.

Country Status (1)

Country Link
ES (1) ES2155752B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product

Also Published As

Publication number Publication date
ES2155752A1 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
ES2091728B1 (en) MONOMERIC INSULIN ANALOG FORMULATIONS.
SE9502167D0 (en) Insulin analog formulations
ES554625A0 (en) A PROCEDURE FOR THE PREPARATION OF A SILICONE COMPOSITION.
EA200100458A1 (en) Antiparasitic drugs
FI963846A (en) Pre-filled syringe showing drops
HN1998000113A (en) ORAL PHARMACEUTICAL PREPARATION INCLUDING A COMPOUND OF ANTI-ULCER ACTIVITY AND PROCEDURE FOR ITS OBTAINING.
AU1539592A (en) Retainer assembly for syringe tip
EA199900580A1 (en) PHARMACEUTICAL DERIVATIVES OF AMINOPHOSPHONE ACID
BRPI9814894A (en) process for the preparation of 8-methoxy-quinolonecarboxylic acids.
ITRM930399A0 (en) USE OF L-CARNITINE OR ACIL L-CARNITINE ESTERS WITH HYDROXY ACIDS TO PRODUCE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES.
SV1999000060A (en) PROCEDURE FOR THE PREPARATION OF (S, S) -BENCIL-2,8-DIAZABICICLO 4.3.0 NONANO REF. 32965-SV
ES556001A0 (en) A PROCEDURE FOR THE PREPARATION OF A SILICONE COMPOSITION.
BR9806501A (en) Compound of ester and pesticide containing the same
MX9301746A (en) NEW ACIDES 9-FLUORO-7-OXO-7H-PIRIDO (1,2,3, -DE) (1,4) -BENZOXACIN-6-CARBOXILICOS AND ITS ESTERS, PROCEDURE FOR THEIR PREPARATION AND DRUGS THAT CONTAIN THEM.
IT8920269A0 (en) PROCEDURE FOR THE PREPARATION OF FLUORINATED ALCOHOL METHACRYLATES.
ES2155752B1 (en) FORMULATIONS OF MONOMERIC INSULIN ANALOGS.
ES551635A0 (en) PROCEDURE FOR THE OBTAINING OF A PHARMACEUTICAL COMPOSITION OF DELAYED RELEASE BASED ON 9,10-DIHYDRO-ALCALOIDS.
DK0815858T3 (en) Pharmaceutical composition containing 9-cis-retinoic acid alpha-tocopherol ester for the treatment of leukemia
BR8804239A (en) PROCESS FOR THE PREPARATION OF A COMPOUND, PRAGUICIDE COMPOSITION, APPLICATION AND PROCESS FOR COMBATING PEST
CA2129527A1 (en) Pharmaceutical composition usable as an analgesic, comprising (r)-(benzoyl-3-phenyl)-2-propionic acid
BR9809439A (en) Processes for preparation of benzothiophenes
FI934468A0 (en) BENSENBORSYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM SYTESMELLANPRODUKTER
MX9302986A (en) MEDICINES CONTAINING METRIFONATE AND PROCEDURE FOR ITS PREPARATION
ES2157232T3 (en) PROCEDURE FOR THE PREPARATION OF 2,4,5-TRIBROMO-PIRROL-3-CARBONITRILE.
AU3641995A (en) Non-reusable syringe with removable plunger usable as a needle guard

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010516

Kind code of ref document: A1

Effective date: 20010516

FD2A Announcement of lapse in spain

Effective date: 20150925